MARIA TUCCI JONES: Open Payments
NPI 1508468745 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,363 in 132 payments from 16 companies in 2025. Trend: 2023 $322 · 2024 $1,636 · 2025 $2,363
Food & beverage: $2,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $898 |
| Madrigal Pharmaceuticals | 11 | $257 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $148 |
| Ardelyx, Inc. | 6 | $112 |
| GENZYME CORPORATION | 5 | $103 |
| Intercept Pharmaceuticals, Inc. | 5 | $86 |
| Ipsen Biopharmaceuticals, Inc | 4 | $83 |
| Celltrion USA Inc. | 5 | $73 |
| Lilly USA, LLC | 4 | $72 |
Products named: RINVOQ, REZDIFFRA, XIFAXAN, LINZESS, DUPIXENT, ENTYVIO, SKYRIZI, IBSRELA.
Industry payments across TN — which companies pay providers there.
